Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease

David Lee, Qiaozhi Lu, Sven D. Sommerfeld, Amanda Chan, Nikhil G. Menon, Tannin A. Schmidt, Jennifer Hartt Elisseeff, Anirudha Singh

Research output: Contribution to journalArticle

Abstract

Hyaluronic acid (HA) solutions effectively lubricate the ocular surface and are used for the relief of dry eye related symptoms. However, HA undergoes rapid clearance due to limited adhesion, which necessitates frequent instillation. Conversely, highly viscous artificial tear formulations with HA blur vision and interfere with blinking. Here, we developed an HA-eye drop formulation that selectively binds and retains HA for extended periods of time on the ocular surface. We synthesized a heterobifunctional polymer-peptide system with one end binding HA while the other end binding either sialic acid-containing glycosylated transmembrane molecules on the ocular surface epithelium, or type I collagen molecule within the tissue matrix. HA solution was mixed with the polymer-peptide system and tested on both ex vivo and in vivo models to determine its ability to prolong HA retention. Furthermore, rabbit ocular surface tissues treated with binding peptides and HA solutions demonstrated superior lubrication with reduced kinetic friction coefficients compared to tissues treated with conventional HA solution. The results suggest that binding peptide-based solution can keep the ocular surface enriched with HA for prolonged times as well as keep it lubricated. Therefore, this system can be further developed into a more effective treatment for dry eye patients than a standard HA eye drop. Statement of Significance Eye drop formulations containing HA are widely used to lubricate the ocular surface and relieve dry eye related symptoms, however its low residence time remains a challenge. We designed a polymer-peptide system for the targeted delivery of HA to the ocular surface using sialic acid or type I collagen as anchors for HA immobilization. The addition of the polymer-peptide system to HA eye drop exhibited a reduced friction coefficient, and it can keep the ocular surface enriched with HA for prolonged time. This system can be further developed into a more effective treatment for dry eye than a standard HA eye drop.

Original languageEnglish (US)
Pages (from-to)163-171
Number of pages9
JournalActa Biomaterialia
Volume55
DOIs
StatePublished - Jun 1 2017

Fingerprint

Hyaluronic acid
Eye Diseases
Hyaluronic Acid
Peptides
Polymers
Ophthalmic Solutions
Friction
N-Acetylneuraminic Acid
Tissue
Collagen Type I
Collagen
Lubrication
Blinking
Molecules
Aptitude
Acids

Keywords

  • Dry eye
  • Eye drops
  • Hyaluronic acid
  • Peptides
  • Sialic acid

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Biomaterials
  • Biomedical Engineering
  • Molecular Biology

Cite this

Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease. / Lee, David; Lu, Qiaozhi; Sommerfeld, Sven D.; Chan, Amanda; Menon, Nikhil G.; Schmidt, Tannin A.; Elisseeff, Jennifer Hartt; Singh, Anirudha.

In: Acta Biomaterialia, Vol. 55, 01.06.2017, p. 163-171.

Research output: Contribution to journalArticle

Lee, David ; Lu, Qiaozhi ; Sommerfeld, Sven D. ; Chan, Amanda ; Menon, Nikhil G. ; Schmidt, Tannin A. ; Elisseeff, Jennifer Hartt ; Singh, Anirudha. / Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease. In: Acta Biomaterialia. 2017 ; Vol. 55. pp. 163-171.
@article{d4fe31d909404ccfaee9e9934506cd46,
title = "Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease",
abstract = "Hyaluronic acid (HA) solutions effectively lubricate the ocular surface and are used for the relief of dry eye related symptoms. However, HA undergoes rapid clearance due to limited adhesion, which necessitates frequent instillation. Conversely, highly viscous artificial tear formulations with HA blur vision and interfere with blinking. Here, we developed an HA-eye drop formulation that selectively binds and retains HA for extended periods of time on the ocular surface. We synthesized a heterobifunctional polymer-peptide system with one end binding HA while the other end binding either sialic acid-containing glycosylated transmembrane molecules on the ocular surface epithelium, or type I collagen molecule within the tissue matrix. HA solution was mixed with the polymer-peptide system and tested on both ex vivo and in vivo models to determine its ability to prolong HA retention. Furthermore, rabbit ocular surface tissues treated with binding peptides and HA solutions demonstrated superior lubrication with reduced kinetic friction coefficients compared to tissues treated with conventional HA solution. The results suggest that binding peptide-based solution can keep the ocular surface enriched with HA for prolonged times as well as keep it lubricated. Therefore, this system can be further developed into a more effective treatment for dry eye patients than a standard HA eye drop. Statement of Significance Eye drop formulations containing HA are widely used to lubricate the ocular surface and relieve dry eye related symptoms, however its low residence time remains a challenge. We designed a polymer-peptide system for the targeted delivery of HA to the ocular surface using sialic acid or type I collagen as anchors for HA immobilization. The addition of the polymer-peptide system to HA eye drop exhibited a reduced friction coefficient, and it can keep the ocular surface enriched with HA for prolonged time. This system can be further developed into a more effective treatment for dry eye than a standard HA eye drop.",
keywords = "Dry eye, Eye drops, Hyaluronic acid, Peptides, Sialic acid",
author = "David Lee and Qiaozhi Lu and Sommerfeld, {Sven D.} and Amanda Chan and Menon, {Nikhil G.} and Schmidt, {Tannin A.} and Elisseeff, {Jennifer Hartt} and Anirudha Singh",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.actbio.2017.03.043",
language = "English (US)",
volume = "55",
pages = "163--171",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease

AU - Lee, David

AU - Lu, Qiaozhi

AU - Sommerfeld, Sven D.

AU - Chan, Amanda

AU - Menon, Nikhil G.

AU - Schmidt, Tannin A.

AU - Elisseeff, Jennifer Hartt

AU - Singh, Anirudha

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Hyaluronic acid (HA) solutions effectively lubricate the ocular surface and are used for the relief of dry eye related symptoms. However, HA undergoes rapid clearance due to limited adhesion, which necessitates frequent instillation. Conversely, highly viscous artificial tear formulations with HA blur vision and interfere with blinking. Here, we developed an HA-eye drop formulation that selectively binds and retains HA for extended periods of time on the ocular surface. We synthesized a heterobifunctional polymer-peptide system with one end binding HA while the other end binding either sialic acid-containing glycosylated transmembrane molecules on the ocular surface epithelium, or type I collagen molecule within the tissue matrix. HA solution was mixed with the polymer-peptide system and tested on both ex vivo and in vivo models to determine its ability to prolong HA retention. Furthermore, rabbit ocular surface tissues treated with binding peptides and HA solutions demonstrated superior lubrication with reduced kinetic friction coefficients compared to tissues treated with conventional HA solution. The results suggest that binding peptide-based solution can keep the ocular surface enriched with HA for prolonged times as well as keep it lubricated. Therefore, this system can be further developed into a more effective treatment for dry eye patients than a standard HA eye drop. Statement of Significance Eye drop formulations containing HA are widely used to lubricate the ocular surface and relieve dry eye related symptoms, however its low residence time remains a challenge. We designed a polymer-peptide system for the targeted delivery of HA to the ocular surface using sialic acid or type I collagen as anchors for HA immobilization. The addition of the polymer-peptide system to HA eye drop exhibited a reduced friction coefficient, and it can keep the ocular surface enriched with HA for prolonged time. This system can be further developed into a more effective treatment for dry eye than a standard HA eye drop.

AB - Hyaluronic acid (HA) solutions effectively lubricate the ocular surface and are used for the relief of dry eye related symptoms. However, HA undergoes rapid clearance due to limited adhesion, which necessitates frequent instillation. Conversely, highly viscous artificial tear formulations with HA blur vision and interfere with blinking. Here, we developed an HA-eye drop formulation that selectively binds and retains HA for extended periods of time on the ocular surface. We synthesized a heterobifunctional polymer-peptide system with one end binding HA while the other end binding either sialic acid-containing glycosylated transmembrane molecules on the ocular surface epithelium, or type I collagen molecule within the tissue matrix. HA solution was mixed with the polymer-peptide system and tested on both ex vivo and in vivo models to determine its ability to prolong HA retention. Furthermore, rabbit ocular surface tissues treated with binding peptides and HA solutions demonstrated superior lubrication with reduced kinetic friction coefficients compared to tissues treated with conventional HA solution. The results suggest that binding peptide-based solution can keep the ocular surface enriched with HA for prolonged times as well as keep it lubricated. Therefore, this system can be further developed into a more effective treatment for dry eye patients than a standard HA eye drop. Statement of Significance Eye drop formulations containing HA are widely used to lubricate the ocular surface and relieve dry eye related symptoms, however its low residence time remains a challenge. We designed a polymer-peptide system for the targeted delivery of HA to the ocular surface using sialic acid or type I collagen as anchors for HA immobilization. The addition of the polymer-peptide system to HA eye drop exhibited a reduced friction coefficient, and it can keep the ocular surface enriched with HA for prolonged time. This system can be further developed into a more effective treatment for dry eye than a standard HA eye drop.

KW - Dry eye

KW - Eye drops

KW - Hyaluronic acid

KW - Peptides

KW - Sialic acid

UR - http://www.scopus.com/inward/record.url?scp=85019726203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019726203&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2017.03.043

DO - 10.1016/j.actbio.2017.03.043

M3 - Article

C2 - 28363785

AN - SCOPUS:85019726203

VL - 55

SP - 163

EP - 171

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

ER -